Translating Evidence Into Practice: Patient-Centered, Guideline-Driven Care in ANCA-Associated Vasculitis
June 04, 2026
Glasgow
Targeting CKD-aP at the Source: Key Mechanisms and Treatments
Steven Fishbane, MD
Maurizio Gallieni, MD
Advancing Care for Women With Aortic Stenosis*: 2-Year Outcomes for Women in the 5-Year SMART Trial
Roxana Mehran, MD, FSCAI
Kappa-Opioid Settings: Real-World Evidence Insights
Lucio Manenti, MD, PhD
Emilio Sanchez, MD, PhD
The Patient-Clinician Connection in Managing CKD-aP
James Burton, DM, FRCP
Improving Sleep and Mental Health in Patients with CKD-aP
Leonie Kraft, MD
Decoding Itch in CKD: From CKD-aP Suspicion to Solution
Quantifying CKD-aP: Tools for Better Care
CKD-aP Treatment Tool Kit
Optimizing RAASi/MRA Therapy in Patients with Heart Failure, CKD, and Hyperkalemia: A Microlearning Curriculum Approach
Javed Butler, MD
Ellie Kelepouris, MD, FACP, FAHA
Patrick Rossignol, MD, PhD
FSGS: When Solutions Fall Short
Meghan Sise, MD
FSGS 360°: From Patient Experience to Precision Medicine
Kenneth Lieberman, MD
Vladimir Tesar
Monitoring FSGS: Traditional and Novel Biomarkers
Emerging Therapies in Managing Adult and Pediatric Patients With FSGS: Latest Data
DEARA Versus SOC in FSGS Management: Clinical Trial Insights
Treatment Considerations for Pediatric Patients With FSGS